Skip to main content
All lobbying filings

WILLIAMS AND JENSEN, PLLC

Lobbying for NOVO NORDISK INC. · Pharmaceutical company

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 21, 2025

Official filing document

 Lobbying activity 5
Copyright/Patent/Trademark

General issues related to patent protections.

Health Issues

Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Public Law 118-47. American Relief Act (P.L. 118-158).

Budget/Appropriations

Support for obesity drug coverage and access.

Medicare/Medicaid

Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Public Law 118-47. American Relief Act (P.L. 118-158).

Taxation/Internal Revenue Code

Issues related to corporate tax and international tax.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem